The CAPTAIN trial has achieved a milestone by becoming the initial randomized controlled study to compare a novel technology with the standard practice of robotic radical prostatectomy and successfully meeting its recruitment goal. This trial marks a significant advancement in medical research, as it aims to evaluate the effectiveness of the new technology against the current standard. The precise number of participants and the specific outcomes of the trial remain undisclosed, but this accomplishment underscores the importance of rigorous scientific investigation in improving patient care.